Skip to main content
OpenTrials

Clinical trial condition

Hypothalamic Diseases

Explore clinical trials studying Hypothalamic Diseases. Study availability and eligibility vary by location and protocol.

589 public trials 88 recruiting studies
Refine in advanced search Browse all conditions

Hypothalamic Diseases trial results

Completed

Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?

NCT01298180

Conditions
Abnormalities, Multiple, Bone Diseases, Bone Diseases, Developmental, +26 more
Locations
  • CHU Amiens Hôpital Nord Service Pédiatrie - Place Victor Pauchet Amiens, France
  • CHU Angers - 4 rue Larrey Angers, France
  • CHG Avignon - 305, rue Raoul Follereau Avignon, France
  • CHU Besançon Hôpital Saint Jacques - 2 Place Saint Jacques Besançon, France
View all 26 locations
View Trial Details
Completed

An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly

NCT00171730

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Cedars Sinai Medical Center Dept. of Pituitary Ctr. Los Angeles, California, United States
  • University of Michigan Health System StudyCoordinatorCSOM230B2201E1 Ann Arbor, Michigan, United States
  • NYU / VA Medical Center New York, United States
  • Novartis Investigative Site Woolloongabba, Queensland, Australia
View Trial Details
Completed

Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency

NCT03874013

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations
  • Aichi Medical University Hospital Nagakute, Aichi-ken, Japan
  • Seirei Sakura Citizen Hospital Sakura, Chiba, Japan
  • Hospital of the University of Occupational and Environmental Health Kitakyushu, Fukuoka, Japan
  • Gunma University Hospital Maebashi, Gunma, Japan
View all 46 locations
View Trial Details
Completed

Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease

NCT00171951

Conditions
Brain Diseases, Central Nervous System Diseases, Cushing Disease, +6 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Oregon Health & Sciences University Dept.ofOregonHealth&SciencesU. Portland, Oregon, United States
  • University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States
  • Novartis Investigative Site Paris, France
View Trial Details
Completed

SOFI: A Quality Improvement Project to Standardize Use of Intravenous Fluids in Hospitalized Pediatric Patients

NCT03924674

Conditions
ADH Inappropriate, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Community Regional Medical Center Fresno, California, United States
  • Loma Linda University Children's Hospital Loma Linda, California, United States
  • Harbor - UCLA Medical Center Los Angeles, California, United States
View all 89 locations
View Trial Details
Completed

Treatment for Endogenous Cushing's Syndrome

NCT01838551

Conditions
Brain Diseases, Central Nervous System Diseases, Endocrine System Diseases, +6 more
Locations
  • UCLA School of Medicine Los Angeles, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Medical Center Ann Arbor, Michigan, United States
View all 42 locations
View Trial Details

Related conditions